Loading...

APC anti-mouse CD86 Antibody

Pricing & Availability
Clone
GL-1 (See other available formats)
Regulatory Status
RUO
Other Names
B7-2, B70, Ly-58
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
GL-1_APC_090707
LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 APC
  • GL-1_APC_090707
    LPS-stimulated (3 days) C57BL/6 mouse splenocytes stained with GL-1 APC
See APC spectral data
Cat # Size Price Quantity Check Availability Save
105011 25 µg 77€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
105012 100 µg 227€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is a ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce co-stimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can also bind to CD152, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
LPS-activated CBA/Ca mouse splenic B cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The GL-1 antibody can block the mixed lymphocyte reaction in vitro and has been shown to inhibit the priming of cytotoxic T lymphocytes in vivo (along with antibodies against B7-1). Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemical staining of acetone-fixed frozen sections2,6, immunofluorescence microscopy, and in vivo and in vitro blocking of T cell responses1-6. GL-1 is not suitable for immunohistochemical staining of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 105051-105056).

Application References
  1. Hathcock KS, et al. 1993. Science 262:905. (Block, IP)
  2. Inaba KM, et al. 1994. J. Exp. Med. 180:1849. (Block, IHC)
  3. Hathcock KS, et al. 1994. J. Exp. Med. 180:631. (Block)
  4. Krummel MF, et al. 1995. J. Exp. Med. 182:459. (Block)
  5. Liu Y, et al. 1997. J. Exp. Med. 185:251. (Block)
  6. Herold KC, et al. 1997. J. Immunol. 158:984. (Block, IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  9. Turnquist HR, et al. 2007. J. Immunol. 178:7018.
  10. Klinger MB, et al. 2007. Am. J. Physiol. Requl. Integr. Comp. Physiol. 293:R677. PubMed
  11. de Verteuil DA, et al. 2014. J Immunol. 193:1121. PubMed
Product Citations
  1. Bhattacharjee P, et al. 2018. Sci Rep. 13:e0199785. PubMed
  2. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  3. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  4. Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
  5. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  6. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  7. Luck H, et al. 2019. Nat Commun. 10:3650. PubMed
  8. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  9. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  10. Arora H, et al. 2019. Immunity. 50:418. PubMed
  11. Finkin S et al. 2019. Immunity. 51(2):324-336 . PubMed
  12. Xiao Y, et al. 2019. JCI Insight. 4:e99052. PubMed
  13. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  14. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  15. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  16. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  17. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  18. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  19. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  20. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  21. Yu X, et al. 2020. Cancer Cell. 37(6):850-866. PubMed
  22. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  23. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  24. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  25. Shepherd J 2011. Toxicol Sci. 120:68. PubMed
  26. Verteuil D, et al. 2014. J Immunol. 193:1121. PubMed
  27. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  28. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  29. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  30. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  31. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  32. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  33. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  34. Huang L, et al. 2021. Frontiers in Cellular and Infection Microbiology. 10:606340. PubMed
  35. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
  36. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  37. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  38. Han F, et al. 2020. Invest Ophthalmol Vis Sci. 61:24. PubMed
  39. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  40. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  41. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  42. Wang Y, et al. 2021. Cell Rep. 35:108948. PubMed
  43. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  44. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  45. Chen G, et al. 2021. Sci Adv. 7:eabg5686. PubMed
  46. Roberts LM, et al. 2021. iScience. 24:103025. PubMed
  47. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  48. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  49. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  50. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  51. Sitnik S, et al. 2020. Mol Ther Oncolytics. 17:190. PubMed
  52. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  53. Wu J, et al. 2021. Mol Med Rep. 23:. PubMed
  54. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  55. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  56. Qian J, et al. 2021. Int J Mol Sci. 22:. PubMed
  57. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  58. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  59. Qiu N, et al. 2021. J Nanobiotechnology. 19:428. PubMed
  60. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  61. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  62. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  63. Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed
  64. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  65. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  66. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  67. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  68. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  69. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  70. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  71. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  72. Zhang X, et al. 2022. JCI Insight. 7:. PubMed
  73. Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed
  74. Gómez LA, et al. 2020. Front Microbiol. 11:1586. PubMed
  75. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  76. Zheng C, et al. 2022. Acta Pharm Sin B. 12:3726. PubMed
  77. Cho H, et al. 2022. Nat Commun. 13:5974. PubMed
  78. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  79. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  80. Zenke S, et al. 2022. Nat Commun. 13:6459. PubMed
  81. D'Avola A, et al. 2022. J Clin Invest. 132: . PubMed
  82. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  83. Li D, et al. 2022. Cell Prolif. 55:e13299. PubMed
  84. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  85. Li Y, et al. 2023. Bioact Mater. 20:548. PubMed
  86. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  87. Meng Z, et al. 2022. Int J Oncol. 61: . PubMed
  88. Xu S, et al. 2022. EBioMedicine. 86:104312. PubMed
  89. Liu M, et al. 2022. Cells. 11: . PubMed
  90. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  91. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  92. Ivasko SM, et al. 2023. Front Immunol. 13:1023206. PubMed
  93. Zhao M, et al. 2023. J Nanobiotechnology. 21:50. PubMed
  94. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  95. Sohn HS, et al. 2022. Sci Adv. 8:eabo5284. PubMed
  96. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  97. Stoler-Barak L, et al. 2023. Nat Commun. 14:1462. PubMed
  98. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  99. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  100. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  101. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  102. Wu N, et al. 2023. Front Bioeng Biotechnol. 11:1173381. PubMed
  103. Zhang J, et al. 2023. Theranostics. 13:2226. PubMed
  104. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
RRID
AB_493343 (BioLegend Cat. No. 105011)
AB_493342 (BioLegend Cat. No. 105012)

Antigen Details

Structure
Ig superfamily, 80 kD
Distribution

B cells and T cells (upregulated upon activation), macrophages, dendritic cells, and astrocytes

Function
T cell costimulation, Ig class-switching, NK cell cytotoxicity
Ligand/Receptor
CD28, CD152 (CTLA-4)
Cell Type
Astrocytes, B cells, Dendritic cells, Macrophages, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Hathcock KS, et al. 1993. Science 262:905.
3. Freeman GJ, et al. 1993. Science 262:907.
4. Carreno BM, et al. 2002. Annu. Rev. Immunol. 20:29.

Gene ID
12524 View all products for this Gene ID
UniProt
View information about CD86 on UniProt.org
Go To Top Version: 1    Revision Date: 11.30.2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account